Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter EndRaising Full-Year Fiscal 2024 Earnings...

Related Keywords

Australia ,Canada ,United States ,America ,American ,Ron Lombardi ,Prestige Consumer Healthcare Inc ,Women Health ,Exchange Commission ,International Healthcare ,Company Annual Report On Form ,Company Investor Relations ,Versus Prior ,Leverage Ratio ,Full Year Fiscal ,Consumer Healthcare ,Chief Executive Officer ,Prestige Consumer ,Fiscal Quarter Ended December ,Dear Care ,North America ,Months Ended December ,Cash Flow ,North American ,Updated Outlook ,Clear Eyes ,Third Quarter ,Accompanying Slide Presentation ,Investor Relations ,Safe Harbor ,Private Securities Litigation Reform Act ,Annual Report ,Little Remedies ,Butt Paste ,Consolidated Statements ,Comprehensive Income ,Revenue Change Percentage ,Net Debt ,Revenue Change ,Fiscal Year ,Markets ,